NDAORALTABLET
Approved
May 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
RUFEN (ibuprofen) by Design Pharmaceuticals is cyclooxygenase inhibitors [moa]. First approved in 1981.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
RUFEN (ibuprofen) is an oral nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes to reduce pain and inflammation. It is indicated for pain management across multiple conditions including osteoarthritis, rheumatoid arthritis, dental pain, postoperative pain, back pain, headache, and dysmenorrhea. The drug has been a cornerstone of OTC and prescription pain management since its 1981 approval.
LOE Approaching
Brand faces significant generic/competitive pressure with approaching LOE; support roles likely focused on defending market share in specialty indications rather than expansion.
Mechanism of Action
Cyclooxygenase Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Effect of Extracorporeal Radial Shock Wave Ibuprofen Phonophoresis on Subacromial Space in Patients With Impingement Syndrome.
Started Mar 2026
70 enrolled
RehabilitationShock WaveImpingement Syndrome
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Started Nov 2023
74 enrolled
Healthy Male and Female Subjects
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain
Started Aug 2022
176 enrolled
Osteoarthritis
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
Started Jun 2022
177 enrolled
Low Back Pain, MechanicalLow Back PainAcute Low Back Pain
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Started Aug 2021
100 enrolled
Intravenous Drug UsageIbuprofenKetorolac+2 more
Worked on RUFEN at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.